Treatment of Stage IE or Stage IIE Primary Pulmonary Hodgkin's Lymphoma

Primary pulmonary Hodgkin's lymphoma presenting at stage IE (disease confined to the lung as the primary extranodal site) or stage IIE (with limited regional nodal involvement) follows a distinct treatment pathway from systemic lymphoma presentations.

This protocol is for patients with stage IE or stage IIE primary pulmonary Hodgkin's lymphoma — Hodgkin's lymphoma arising primarily in the lung, classified by the extent of extranodal and nodal involvement at presentation.

Treatment Approach

Management in this setting is built around a chemotherapy-based strategy. Whether radiotherapy is incorporated alongside systemic therapy, and the specific regimen selection and sequencing, are detailed in the full protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.21037/jtd-24-1524

In contrast, chemotherapy or combination chemotherapy plus low-dose involved-field radiotherapy (LD-IFRT) is the standard treatment option for HL.

View source ↗